Bibliotecas PUC-SP - Busca Integrada

Systematic literature review on early clinical evidence for immune-resolution therapies and potential benefits to patients and healthcare providers

de réir Paul Klekotka, Louis Lavoie, Beth Mitchell, Ike Iheanacho, Russel Burge, Russel Burge, Andrea Cohee, Joanne Puckett, Ajay Nirula
Foilsithe in Frontiers in Immunology (2024-10-01)

Moderate-to-severe plaque psoriasis patients treated with ixekizumab: early real-world outcomes and adverse events

de réir Wayne Gulliver, Michelle Penney, Rebecca Power, Susanne Gulliver, Sonia Montmayeur, Russel Burge
Foilsithe in Journal of Dermatological Treatment (2022-01-01)

Assessing the Impact of Improvements in PASI and Itch Scores on Patients’ Quality of Life in the Treatment of Psoriasis

de réir Gil Yosipovitch, Yan Dong, Russel Burge, Baojin Zhu, David Shrom, Alexa B. Kimball
Foilsithe in Acta Dermato-Venereologica (2019-07-01)

Relationship Between Rapid Skin Clearance and Quality of Life Benefit: Post Hoc Analysis of Japanese Patients with Moderate-to-Severe Psoriasis Treated with Ixekizumab (UNCOVER-J)

de réir Masaru Honma, Zhihong Cai, Russel Burge, Baojin Zhu, Sohiya Yotsukura, Hitoe Torisu-Itakura
Foilsithe in Dermatology and Therapy (2020-09-01)

Psoriasis treatment patterns and outcomes with ixekizumab in a real-world setting: results from a single US dermatology referral practice

de réir Craig Leonardi, Rei Tao, Solmaz Setayeshgar, Sisi Wang, Russel Burge, Baojin Zhu, William N. Malatestinic
Foilsithe in Journal of Dermatological Treatment (2022-05-01)

Greater cumulative benefits from ixekizumab versus ustekinumab treatment over 52 weeks for patients with moderate-to-severe psoriasis in a randomized, double-blinded phase 3b clini...

de réir Andrew Blauvelt, Mark Lomaga, Russel Burge, Baojin Zhu, Wei Shen, David Shrom, Martin Dossenbach, Andreas Pinter
Foilsithe in Journal of Dermatological Treatment (2020-02-01)

Posthospital Discharge Medical Care Costs and Family Burden Associated with Osteoporotic Fracture Patients in China from 2011 to 2013

de réir Zhao Xie, Russel Burge, Yicheng Yang, Fen Du, Tie Lu, Qiang Huang, Wenyu Ye, Weihua Xu
Foilsithe in Journal of Osteoporosis (2015-01-01)

Ixekizumab treatment patterns and healthcare utilization and costs for patients with psoriasis

de réir Mwangi J. Murage, Adrienne M. Gilligan, Oth Tran, Orin Goldblum, Russel Burge, Chen-Yen Lin, Abrar Qureshi
Foilsithe in Journal of Dermatological Treatment (2021-01-01)

Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses

de réir Richard B. Warren, Kyoungah See, Russel Burge, Ying Zhang, Alan Brnabic, Gaia Gallo, Alyssa Garrelts, Alexander Egeberg
Foilsithe in Dermatology and Therapy (2019-11-01)

Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort

de réir Alexander Egeberg, Yuki M F Andersen, Amy M DeLozier, Lea Nymand, Russel Burge, Emily Edson-Heredia
Foilsithe in BMJ Open (2022-02-01)

Long-term Impact of Ixekizumab on Psoriasis Itch Severity: Results from a Phase III Clinical Trial and Long-term Extension

de réir Alexandra B. Kimball, Thomas Luger, Alice Gottlieb, Luis Puig, Roland Kaufmann, Russel Burge, Chen-Yen Lin, Gil Yosipovitch
Foilsithe in Acta Dermato-Venereologica (2017-10-01)

Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: pooled results fro...

de réir Andrew Blauvelt, Leon Kircik, Todd Schlesinger, Evangeline Pierce, Russel Burge, Michael Behling, Amber Reck Atwater, Hany ElMaraghy, April Armstrong
Foilsithe in Journal of Dermatological Treatment (2025-12-01)

Ixekizumab Real-World Effectiveness at 24 Weeks in Patients with Psoriasis: Data from the United States Taltz Customer Support Program

de réir Alice B. Gottlieb, Russel Burge, William N. Malatestinic, Baojin Zhu, Yunyang Zhao, Julie McCormack, Miriam Kimel, Joseph F. Merola
Foilsithe in Dermatology and Therapy (2023-07-01)

Understanding Treatment Preferences in Patients with Moderate to Severe Plaque Psoriasis in the USA: Results from a Cross-Sectional Patient Survey

de réir Joe Gorelick, David Shrom, Kiran Sikand, Lisa Renda, Russel Burge, Christine Dworkin, Craig Krebsbach, Ripsi P. Patel, Chitra Karki, David Rosmarin
Foilsithe in Dermatology and Therapy (2019-10-01)

Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial

de réir Lyn Guenther, Alison Potts Bleakman, Jamie Weisman, Yves Poulin, Lynda Spelman, Russel Burge, Janelle Erickson, Kristin Todd, Clinton C. Bertram, Caitriona Ryan
Foilsithe in Acta Dermato-Venereologica (2020-01-01)

Development of the Psoriasis Symptoms Scale (PSS) in patients with moderate-to-severe psoriasis: qualitative and quantitative analyses

de réir April W. Armstrong, Emily Edson-Heredia, April N. Naegeli, Russel Burge, Jiat-Ling Poon, Milena Anatchkova, Luna Sun, Baojin Zhu, Kathleen W. Wyrwich
Foilsithe in Journal of Dermatological Treatment (2020-07-01)

Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by...

de réir Alexander Egeberg, Jason E. Hawkes, Najwa Somani, Russel Burge, Kyoungah See, Gaia Gallo, Missy McKean-Matthews, Melinda Gooderham, George Han, April Armstrong
Foilsithe in Dermatology and Therapy (2024-04-01)

Improvement in general touch avoidance in patients with moderate‐to‐severe genital psoriasis treated with ixekizumab during a 52‐week, randomized, phase 3 clinical trial (IXORA‐Q)...

de réir Jennifer Soung, Jennifer C. Cather, Melinda Gooderham, Caitriona Ryan, Najwa Somani, Meghan Feely, Kyoungah See, Russel Burge, Mohamed Elrayes, Gaia Gallo, April W. Armstrong
Foilsithe in JEADV Clinical Practice (2023-06-01)

Disease response and patient-reported outcomes among initiators of ixekizumab

de réir Mona Shahriari, Ryan W. Harrison, Russel Burge, Chen-Yen Lin, William N. Malatestinic, Orin M. Goldblum, Robert R. McLean, Margaux M. Crabtree, Jacqueline O’Brien, Elsie L. Grace, Mwangi J. Murage
Foilsithe in Journal of Dermatological Treatment (2022-04-01)

Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials

de réir Craig Leonardi, Kristian Reich, Peter Foley, Hideshi Torii, Sascha Gerdes, Lyn Guenther, Melinda Gooderham, Laura K. Ferris, Christopher E. M. Griffiths, Hany ElMaraghy, Heidi Crane, Himanshu Patel, Russel Burge, Gaia Gallo, David Shrom, Ann Leung, Chen-Yen Lin, Kim Papp
Foilsithe in Dermatology and Therapy (2020-03-01)